Formulary Change
FORMULARY UPDATES
EFFECTIVE MAY 10, 2021
CHA is pleased to be able to remove prior authorization requirements for a number of commonly used medication. This will help to reduce the administrative burden for all and streamline care.
FORMULARY CHANGES:
- HYDROXYZINE HCL (PA REMOVED)
- HYDROXYZINE PAMOATE (PA REMOVED)
- FLUTICASONE NASAL SPRAY (PA REMOVED)
- BACLOFEN 10MG AND 20MG TABLETS (PA REMOVED)
- CYCLOBENZAPRIINE 5MG AND 10MG TABLETS (PA REMOVED)
- METHOCARBAMOL 500MG AND 750MG TABLETS (PA REMOVED)
- TIZANIDINE 2MG AND 4MG TABLETS (PA REMOVED)
- GABAPENTIN (QTY RESTRICTION REMOVED)
FORMULARY ADDITIONS:
- OTC VOLTAREN ARTHRITIS PAIN (NO PA REQUIRED—QL 100 GRAMS PER 30 DAYS)
CHOICE 90 ADDITIONS:
- FLUORIDE CHEWABLES
- MULTIVITAMIN WITH FLUORIDE CHEWABLES
- PRENATAL PLUS VITAMINS
- OXYBUTYNIN 5MG TABLETS
Another important opportunity to reduce administrative burden and improve patient compliance is to prescribe 90 day quantities for long-tern generic medications. Eligible 90-day medications for CHA patients can be accessed in our Covered Drugs and on pages 52-53 of the current formulary book. ATRIO covers 90 day fills for nearly all medications that are not controlled substances.